25 results
8-K
YTEN
Yield10 Bioscience Inc
23 May 07
Departure of Directors or Principal Officers
12:00am
of Directors of Metabolix, Inc. (the “Company”) approved 2007 executive compensation for all executive officers except the President and Chief Executive Officer … elements: base salary, a performance-based incentive bonus program, and stock options.
As part of the executive compensation approved on May 17, 2007
8-K
YTEN
Yield10 Bioscience Inc
22 May 14
Submission of Matters to a Vote of Security Holders
12:00am
Shaulson to the Company’s Board of Directors for three-year terms expiring at the 2017 Annual Meeting of Stockholders, approved our executive … compensation by non-binding advisory vote (“say-on-pay”), and ratified the selection of PricewaterhouseCoopers LLP as the Company’s independent registered
8-K
YTEN
Yield10 Bioscience Inc
24 May 11
Metabolix Announces Exercise of Underwriters’ Over-Allotment Option and Closing of $51.7 Million Public Offering of Common Stock
12:00am
, (iii) selected three years, on a non-binding, advisory basis, as the frequency of holding future advisory votes on the Company’s executive … compensation and (iv) ratified the selection of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for 2011. The final
DEF 14A
qkrwnlfko
12 Apr 07
Definitive proxy
12:00am
S-1/A
c16 cryi5x
31 Aug 06
IPO registration (amended)
12:00am